Д. Набер

560 total citations
26 papers, 398 citations indexed

About

Д. Набер is a scholar working on Psychiatry and Mental health, Clinical Psychology and Philosophy. According to data from OpenAlex, Д. Набер has authored 26 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 4 papers in Clinical Psychology and 4 papers in Philosophy. Recurrent topics in Д. Набер's work include Schizophrenia research and treatment (13 papers), Mental Health and Psychiatry (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Д. Набер is often cited by papers focused on Schizophrenia research and treatment (13 papers), Mental Health and Psychiatry (4 papers) and Attention Deficit Hyperactivity Disorder (3 papers). Д. Набер collaborates with scholars based in Germany, Italy and Denmark. Д. Набер's co-authors include Hanns Hippius, D. Pickar, Martin Lambert, Anne Karow, Misha Cohen, Thomas C. Baghai, R Spatz, W. Günther, H Hippius and Katrin Schröeder and has published in prestigious journals such as Biological Psychiatry, Schizophrenia Research and Acta Psychiatrica Scandinavica.

In The Last Decade

Д. Набер

25 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Д. Набер Germany	10	250	83	71	58	44	26	398
Mike A. McPhillips United Kingdom	9	235 0.9×	130 1.6×	83 1.2×	43 0.7×	43 1.0×	16	450
Mary E. Swigar United States	14	216 0.9×	114 1.4×	66 0.9×	34 0.6×	29 0.7×	30	470
G.N. Christodoulou Greece	12	191 0.8×	51 0.6×	49 0.7×	35 0.6×	63 1.4×	46	418
H. A. McClelland United Kingdom	13	300 1.2×	67 0.8×	47 0.7×	60 1.0×	46 1.0×	25	518
Prakash G. Ettigi United States	11	211 0.8×	84 1.0×	63 0.9×	35 0.6×	61 1.4×	17	512
Christian L. Shriqui Canada	7	221 0.9×	115 1.4×	32 0.5×	38 0.7×	33 0.8×	18	380
Rosa Dueñas Spain	12	330 1.3×	170 2.0×	40 0.6×	28 0.5×	36 0.8×	21	525
Mimi C. Roberts South Africa	9	186 0.7×	122 1.5×	26 0.4×	37 0.6×	77 1.8×	13	392
Lilliana Dell’Osso Italy	12	325 1.3×	130 1.6×	39 0.5×	51 0.9×	76 1.7×	21	500
J. Andersen Denmark	10	204 0.8×	82 1.0×	44 0.6×	32 0.6×	84 1.9×	16	370

Countries citing papers authored by Д. Набер

Since Specialization

Citations

This map shows the geographic impact of Д. Набер's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Д. Набер with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Д. Набер more than expected).

Fields of papers citing papers by Д. Набер

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Д. Набер. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Д. Набер. The network helps show where Д. Набер may publish in the future.

Co-authorship network of co-authors of Д. Набер

This figure shows the co-authorship network connecting the top 25 collaborators of Д. Набер. A scholar is included among the top collaborators of Д. Набер based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Д. Набер. Д. Набер is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huber, Christian G., Annekatrin Hoppe, Agorastos Agorastos, et al.. (2012). Are Ratings on the Positive and Negative Syndrome Scale for Schizophrenia Biased by Personality Traits?. Pharmacopsychiatry. 45(4). 156–161. 3 indexed citations

Huber, Christian G., Daniel Schöttle, Michelle Lambert, et al.. (2011). Applicability of the Clinical Global Impressions-Aggression (CGI-A) Scale for Use in File Audit Trials. Pharmacopsychiatry. 44(5). 189–192. 9 indexed citations

Schennach-Wolff, Rebecca, H.-J. Möller, Markus Jäger, et al.. (2010). A Critical Analysis and Discussion of the Appropriateness of the Schizophrenia Consensus Remission Criteria in Clinical Pharmaceutical Trials. Pharmacopsychiatry. 43(7). 245–251. 2 indexed citations

Crocq, M.A., Д. Набер, M Lader, et al.. (2010). Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. European Neuropsychopharmacology. 20(12). 829–838. 19 indexed citations

Suarez, David L., et al.. (2009). Reasons and Outcomes of Olanzapine Dose Adjustments in the Outpatient Treatment of Schizophrenia. Pharmacopsychiatry. 42(4). 135–140. 7 indexed citations

Набер, Д., Anne Karow, & Martin Lambert. (2005). Subjective well‐being under neuroleptic treatment and its relevance for compliance. Acta Psychiatrica Scandinavica. 111(s427). 29–34. 79 indexed citations

Набер, Д., et al.. (2005). PMH58 THE ELECTRONIC SCHIZOPHRENIA TREATMENT ADHERENCE REGISTRY—E-STAR: BASELINE RESULTS FOR GERMANY. Value in Health. 8(3). 402–403. 1 indexed citations

Laux, Gerd, et al.. (2003). PMH10 COSTS AND EFFECTS OF RISPERDAL CONSTATM IN COMPARISON TO CONVENTIONAL DEPOT AND SHORT-ACTING ATYPICAL FORMULATIONS IN GERMANY. Value in Health. 6(6). 691–692. 7 indexed citations

Briken, Peer, et al.. (2002). Atypische Neuroleptika in der Behandlung von Aggressivität und Feindseligkeit bei schizophrenen Patienten. Fortschritte der Neurologie · Psychiatrie. 70(3). 139–144. 4 indexed citations

10.

Altamura, A. Carlo, Julio Bobes, David Owens, et al.. (2000). Principles of Practice from the European Expert Panel on the Contemporary Treatment of Schizophrenia. International Journal of Psychiatry in Clinical Practice. 4(1). 1–11. 12 indexed citations

11.

Pajonk, Frank–Gerald, et al.. (1998). Clozapine versus risperidone: An open, comparative and prospective study on efficacy, tolerability and quality of life. European Neuropsychopharmacology. 8. S223–S223. 3 indexed citations

12.

Barnas, C., István Bitter, W. W. Fleischhacker, et al.. (1997). Treatment of schizophrenic disorders: Algorithms for acute pharmacotherapy. International Journal of Psychiatry in Clinical Practice. 1(sup1). S25–S30. 5 indexed citations

13.

Набер, Д.. (1997). Subjective effects of neuroleptic drugs. Biological Psychiatry. 42(1). 61S–61S. 1 indexed citations

14.

Набер, Д., et al.. (1995). Algorithms for the treatment of schizophrenia.. PubMed. 31(3). 461–7. 10 indexed citations

15.

Klauß, Volker, Д. Набер, Ursula Kronawitter, et al.. (1994). HIV-related ocular microangiopathic syndrome and cognitive functioning. PubMed. 6(3). 252–8. 18 indexed citations

16.

Günther, W., Thomas C. Baghai, Д. Набер, R Spatz, & Hanns Hippius. (1993). EEG Alterations and Seizures during Treatment with Clozapine. Pharmacopsychiatry. 26(3). 69–74. 56 indexed citations

17.

Набер, Д.. (1991). Efficacy and tolerability of the partial dopamine agonist SDZ HDC 912 in the treatment of schizophrenia. Schizophrenia Research. 4(3). 323–323. 1 indexed citations

18.

Набер, Д. & Mireille E. Schnitzer. (1990). [The so-called "AIDS phobia". Symptoms and diagnostic classification of a current hypochondriacal syndrome in hospitalized psychiatric patients].. PubMed. 61(9). 536–40. 1 indexed citations

19.

Albus, Margot, et al.. (1986). Clinical and Biochemical Effects of Nicergoline in Chronic Schizophrenic Patients. Pharmacopsychiatry. 19(3). 101–105. 2 indexed citations

20.

Набер, Д., et al.. (1983). Repeated High Dosage Naloxone Treatment without Therapeutic Efficacy in Schizophrenic Patients*. Pharmacopsychiatry. 16(2). 43–45. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact